effectiveness of high dose pralidoxime for treatment of organophosphate poisoning
Authors
abstract
background: for effective treatment of organophosphate (op) poisoning, development of a standardized protocol with flexible dose regimen for atropine and pralidoxime is an essential step. in this study, we aimed to assess the protocol devised in our setting; bach mai hospital poison treatment center, for treatment of op poisoning that included a higher dose regimen of pralidoxime (2pam). methods: a protocol for treatment of op poisoning was developed during 1995 to 1996, which included an atropinization scoring scale and a modification of 2pam dose regimen. in this study, op poisoned patients who were treated during 1997 to 2002 with the new protocol (study group or cases) were compared with historical control group which included op poisoned patients treated between 1993 and 1994 prior to establishment of the new protocol. results: one-hundred and eight cases and 54 controls were included. the cases and controls were not significantly different according to age, gender and plasma cholinesterase activity on admission from each other. there was no significant difference of mean duration of 2pam therapy between the two groups. the controls received mean total 2pam dose of 7.2±4.1 g, while the patients in the study group received 20.0±12.7 g which was 2.77 times higher than the dose for control group (p< 0.001). patients in the study group received significantly lower doses of atropine (100.2±119.1 vs. 231.8±225.5, p< 0.001). patients in the study group required a shorter duration of hospital stay compared to controls (6.2±4.8 vs. 8.2±5.8, p=0.035). in addition, morality rate decreased significantly (p=0.004) from 13% to 1.9% by application of the new protocol. conclusion: the new protocol was more effective for patients with op toxicity as it reduced the morbidities and mortality. a flexible regimen of 2pam therapy for op poisoning is recommended to be implemented.
similar resources
Effectiveness of High Dose Pralidoxime for Treatment of Organophosphate Poisoning
Background: For effective treatment of organophosphate (OP) poisoning, development of a standardized protocol with flexible dose regimen for atropine and pralidoxime is an essential step. In this study, we aimed to assess the protocol devised in our setting; Bach Mai Hospital Poison Treatment Center, for treatment of OP poisoning that included a higher dose regimen of pralidoxime (2PAM). Method...
full textEffectiveness of High Dose Pralidoxime for Treatment of Organophosphate Poisoning
Background: For effective treatment of organophosphate (OP) poisoning, development of a standardized protocol with flexible dose regimen for atropine and pralidoxime is an essential step. In this study, we aimed to assess the protocol devised in our setting; Bach Mai Hospital Poison Treatment Center, for treatment of OP poisoning that included a higher dose regimen of pralidoxime (2PAM). Method...
full textPralidoxime for organophosphate poisoning
From their randomised trial, Kirti Pawar and colleagues report in today’s Lancet on two pralidoxime-dosing schemes in 200 patients who had moderately severe self-poisoning with organophosphorus insecticide. After a 2-g loading dose over 30 min, half received a high-dose regimen of 1 g/h pralidoxime iodide for 48 h. The other half received a lower dose: 1 g/h every 4 h. After 48 h, the lower dos...
full textWhy Do the Results of Studies on the Effectiveness of Pralidoxime for Treatment of Organophosphate Poisoning Vary?
Organophosphate (OP) compounds are frequently used agorchemicals for deliberate self-harm in some parts of the world resulting in high mortality and morbidity. Pralidoxime (2PAM) is the most widely used and trialed oxime for treatment of OP poisoning. There have been variations over the results of trials using 2PAM for OP poisoning. 2PAM therapy has led to favorable outcomes in some studies, wh...
full textA Study on Two Dose Regimens of Pralidoxime in the Management of Organophosphate Poisoning
Background: The role and proper dose of pralidoxime in the treatment of Organophosphorus (OP) compounds poisoning is an unresolved issue .This study was designed to compare the regimen recommended by the World Health Organization (WHO) with the commonly used standard regimen of pralidoxime. Methods: This was a randomized open labeled prospective study on OP poisoned patients admitted to JSS Hos...
full textMy Resources
Save resource for easier access later
Journal title:
asia pacific journal of medical toxicologyجلد ۳، شماره ۳، صفحات ۹۷-۱۰۳
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023